Listed

Colgate Palmolive Co: Form 10-Q for the period ended Mar 31, 2026

Filed with the SEC on May 1, 2026 and accepted by EDGAR at May 1, 2026, 08:16 ET.

Share

Management's discussion and analysis

As filed, 1,961 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

On March 20, 2025, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2025 Program”), which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended March 31, 2026:

Month Total Number of Shares Purchased(1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions)
January 1 through 31, 2026 3,038 $84.52 — $4,087
February 1 through 28, 2026 975,160 $95.90 691,300 $4,021
March 1 through 31, 2026 2,408,652 $88.02 2,404,356 $3,809
Total 3,386,850 $90.28 3,095,656

(1) Includes share repurchases under the 2025 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

(2) The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 291,194 shares, which represents shares deemed surrendered to the Company to satisfy certain employee elections under the Company’s compensation and benefit programs.

(3) Includes approximate dollar value of shares that were available to be purchased under the publicly announced plans or programs that were in effect as of March 31, 2026.

Risk factors

As filed, 186 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors disclosed in “Risk Factors” in Part 1, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2026-01-01 to 2026-03-31$5.32bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2026-01-01 to 2026-03-31$2.10bnus-gaap:CostOfRevenue
Gross profit3 months2026-01-01 to 2026-03-31$3.23bnus-gaap:GrossProfit
Selling, general and administrative3 months2026-01-01 to 2026-03-31$2.08bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2026-01-01 to 2026-03-31$964.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2026-01-01 to 2026-03-31$62.0mus-gaap:InterestExpenseNonoperating
Income tax3 months2026-01-01 to 2026-03-31$211.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2026-01-01 to 2026-03-31$646.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2026-01-01 to 2026-03-31$0.80us-gaap:EarningsPerShareDiluted
Basic EPS3 months2026-01-01 to 2026-03-31$0.81us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2026-01-01 to 2026-03-31805,100,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2026-01-01 to 2026-03-31$747.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2026-01-01 to 2026-03-31$138.0mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases3 months2026-01-01 to 2026-03-31$306.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2026-03-31$1.33bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2026-03-31$6.08bnus-gaap:AssetsCurrent
Total assetsAt period end2026-03-31$16.61bnus-gaap:Assets
Current liabilitiesAt period end2026-03-31$5.93bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2026-03-31$16.12bnus-gaap:Liabilities
Long-term debtAt period end2026-03-31$7.94bnus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2026-03-31$145.0mus-gaap:StockholdersEquity
Shares outstandingAt period end2026-03-31800,189,310 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000021665-26-000023. Last ingested by Listed: Nov 13, 2026, 16:05 ET. Listed shows no prices and gives no investment advice.